β 2 adrenergic receptor 5′ haplotypes influence promoter activity

British Journal of Pharmacology

Volumn 137, Issue 8, 2002, Pages 1213-1216

  Johnatty, Sharon E ^a   Abdellatif, Maha ^c   Shimmin, Lawrence ^a   Clark, Richard B ^d   Boerwinkle, Eric ^a,b  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

ADRB2; beta2 adrenergic receptor; Haplotype; HEK293 cells; Human 2 adrenergic receptor; Luciferase; Polymorphisms; Promoter; Transfection

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; LUCIFERASE;

ARTICLE; BASE PAIRING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INDUCTION; GENE CONTROL; GENETIC POLYMORPHISM; GENETIC TRANSCRIPTION; HAPLOTYPE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RNA TRANSLATION;

CELL LINE; HAPLOTYPES; HUMANS; LUCIFERASES; MUTATION; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RECEPTORS, ADRENERGIC, BETA-2; STATISTICS, NONPARAMETRIC; TRANSFECTION;

EID: 12244272178     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0704935     Document Type: Article

References (14)

1. Bray, M.S., Krushkal, J., Li, L., Ferrel, R., Kardia, S., Sing, C.F., Turner, S.T. & Boerwinkle, E. (2000). Positional genomic analysis identifies the β2-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation, 101, 2877-2882.
2. Chruscinski, A.J., Rohrer, D.K., Schauble, E., Desai, K.H., Bernstein, D. & Kobilka, B.K. (1999). Targeted disruption of the β2 adrenergic receptor gene. J. Biol. Chem., 274, 16694-16700.
3. Cornett, L.E., Hiller, F.C., Jacobi S.E., Cao, W. & McGraw, D.W. (1998). Identification of a glucocorticoid response element in the rat β2-adrenergic receptor gene. Mol. Pharmacol., 54, 1016-1023.
4. Deng, W.P. & Nickoloff, J.A. (1992). Site-directed mutagenesis of virtually any plasmid by elimination of unique sites. Anal. Biochem., 200, 81.
5. Drysdale, C.M., McGraw, D.W., Stack, CB., Stephens, J.C., Judson, R.S., Nandalban, K., Arnold, K., Ruano, G. & Liggett, SB. (2000). Complex promoter and coding region β2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. Proc. Natl. Acad. Sci., 97, 10483-10488.
6. Guimarães, S. & Moura, D. (2001). Vascular adrenoceptors: An update. Pharmacol. Rev., 53, 319-356.
7. Kobilka, B. (1991). Molecular and cellular biology of adrenergic receptors. Trends Cardiovasc. Med., 1, 189-194.
8. Kobilka, B.K., Frielle, T., Dohlman, H.G., Bolanowski, M.A., Dixon, R.A.F., Keller, P., Caron, M.G. & Lefkowitz, R.J. (1987). Delineation of the intronless nature of the genes for the human and hamster β2-adrenergic receptor and their putative promoter regions. J. Biol. Chem., 262, 7321-7327.
9. Krushkal, J., Ferrel, R., Mockrin, S., Turner, S., Sing, C. & Boerwinkle, E. (1999). Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation, 99, 1407-1410.
10. McGraw, D.W., Forbes, S.L., Kramer, L.A. & Liggett, S.B. (1998). Polymorphisms of the 5′ leader cistron of the human β2-adrenergic receptor regulate receptor expression. J. Clin. Invest., 102, 1927-1932.
11. Parola, A.L. & Kobilka, B.K. (1994). The peptide product of a 5′ leader cistron in the beta2-adrenergic receptor mRNA inhibits receptor synthesis. J. Biol. Chem., 269, 4497-4505.
12. Scott, M.G.H., Swan, C., Wheatley, A.P. & Hall, I.P. (1999). Identification of novel polymorphisms within the promoter region of the human β2 adrenergic receptor gene. Br. J. Pharmacol., 126, 841-844.
13. Turki, J., Pak, J., Green, S.A., Martin, R.J. & Liggett, S.B. (1995). Genetic polymorphisms of the β2-adrenergic receptor in nocturnal and nonnocturnal asthma: Evidence that Gly16 correlates with the nocturnal phenotype. J. Clin. Invest., 95, 1635-1641.
14. Yamada, K., Ishiyama-Shigemoto, S., Ichikawa, F., Yuan, X., Koyanagi, A., Koyama, W. & Nonaka, K. (1999). Polymorphism in the 5′-leader cistron of the β2-adrenergic receptor gene associated with obesity and Type 2 diabetes. J. Clin. Endocrinol. Metab., 84, 1754-1757.